Horizon Therapeutics PLC

NAS: HZNP

GO
/marketstate/country/us

Market open

 --Real time quotes

May 24, 2022, 11:38 a.m.

/zigman2/quotes/206690250/composite

$

88.36

Change

+0.98 +1.12%

Volume

Volume 529,657

Real time quotes

/zigman2/quotes/206690250/composite

Previous close

$ 87.38

$ 88.36

Change

+0.98 +1.12%

Day low

Day high

$87.12

$89.45

Open

52 week low

52 week high

$82.51

$120.54

Open

William Francis Daniel

Presently, William Francis Daniel is Non-Executive Chairman for Malin Corp. Plc. He is also on the board of Elan Pharma International Ltd. and Horizon Therapeutics Plc.

In his past career Mr. Daniel occupied the position of Head-Finance for An Post Group, Financial Director at Xtravision Plc, Secretary & Executive Vice President at Elan Corp. Plc, President & Director at Institute of Directors In Ireland and President of Financial Executives Association.

He received an undergraduate degree from University College Dublin.

Transactions

Date Shares Transaction Value
04/29/2022 1,139   Derivative/Non-derivative trans. at $98.56 per share. 112,260
04/29/2022 4,223   Derivative/Non-derivative trans. at $0 per share. 0
05/10/2021 166   Disposition at $87.01 per share. 14,444
05/10/2021 19,834   Disposition at $86.56 per share. 1,716,832
05/10/2021 20,000   Derivative/Non-derivative trans. at $12.7 per share. 254,000
04/30/2021 2,993   Derivative/Non-derivative trans. at $94.62 per share. 283,198
04/30/2021 11,098   Derivative/Non-derivative trans. at $0 per share. 0
05/02/2020 4,151   Derivative/Non-derivative trans. at $35.62 per share. 147,859
05/02/2020 15,390   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2019 4,132   Derivative/Non-derivative trans. at $26.54 per share. 109,664
05/03/2019 15,320   Derivative/Non-derivative trans. at $0 per share. 0
05/03/2018 14,054   Derivative/Non-derivative trans. at $0 per share. 0
09/19/2017 2,381   Derivative/Non-derivative trans. at $12.1 per share. 28,811
09/19/2017 7,874   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Timothy P. Walbert
Chairman, President & Chief Executive Officer
Mr. Aaron L. Cox
Chief Financial Officer & Executive Vice President
Dr. Karin Rosen
Chief Scientific Officer
Dr. Elizabeth H. Z. Thompson
Executive Vice President-Research & Development
Dr. Jeffrey W. Sherman
Chief Medical Officer & Executive Vice President
Mr. Michael A. DesJardin
Executive VP-Technical Operations & Quality
Dr. Jeffrey D. Kent
Executive VP-Medical Affairs & Outcomes Research
Mr. Andy Pasternak
Chief Strategy Officer & Executive Vice President
Ms. Holly Copeland
Senior Director-Corporate Social Responsibility
Ms. Marilyn Vetter
Group Vice President-Market Access
Mr. Vikram Karnani
President-International & Executive Vice President
Mr. Miles W. McHugh
Chief Accounting Officer & Senior Vice President
Ms. Tina Ventura
Chief Investor Relations Officer & Senior VP
Ms. Jane Gonnerman
Chief of Staff & Group Vice President-Development
Ms. Irina P. Konstantinovsky
EVP, Chief Human Resources & Diversity Officer
Mr. David Caraher
Secretary
Mr. Sean M. Clayton
Executive Vice President & General Counsel
Dr. Susan Mahony
Independent Director
Mr. Michael G. Grey
Lead Independent Director
Dr. Jeff Himawan
Independent Director
Mr. William Francis Daniel
Independent Director
Ms. Pascale Witz
Independent Director
Dr. James Samuel Shannon
Independent Director
Mr. H. Thomas Watkins
Independent Director
Mr. Gino Santini
Independent Director
Link to MarketWatch's Slice.